This compound is a pharmaceutical intermediate featuring a complex polycyclic structure containing fluorine atoms, an ether linkage, and a sulfur-containing ring. It is primarily used in the manufacturing of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2136287-69-7
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(phenylmethoxy)-, (12aR)-
pharmaceutical intermediate
Baloxavir marboxil
pharmaceutical raw material
4-Chloro-3-(3-methoxypropoxy)-5-nitrobenzamide
pharmaceutical intermediate
2-Chloro-3-fluoronitrobenzene
pharmaceutical intermediate
2-Chloro-3-fluoroaniline
pharmaceutical intermediate
2'-O-methylguanosine
pharmaceutical intermediate
Baloxavir
pharmaceutical raw material
(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-11-hexoxy-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-9,12-dione
DLJYUQAKCYNPSB-VPUSJEBWSA-N
CCCCCCOC1=C2C(=O)N3CCOC[C@H]3N(N2C=CC1=O)[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F